SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-014705
Filing Date
2024-05-28
Accepted
2024-05-28 18:13:59
Documents
1
Period of Report
2024-05-23

Document Format Files

Seq Description Document Type Size
1 form4-05282024_100554.html 4  
1 form4-05282024_100554.xml 4 4029
  Complete submission text file 0001415889-24-014705.txt   5594
Mailing Address C/O ACCELERON PHARMA INC. 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Dable Habib J (Reporting) CIK: 0001690773 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40431 | Film No.: 24993438

Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Issuer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)